Science Diabetes mellitus

Eilon Ram 1 2, Leonid Sternik 3 4, Robert Klempfner 5 4, Zaza Iakobishvili 4 6, Enrique Z Fisman 4, Alexander Tenenbaum 4, Elchanan Zuroff 3 4, Yael Peled 5 4, Ehud Raanani 3 4 Main idea: While type 2 DM did not influence the in-hospital mortality hazard, we showed that the presence of DM […]

We prepared 3 different options for this article, therefore you can choose the option that suits you the most: Original – a scientific text with all terms and abbreviations that scientists usually use; Easy – an option that describes the topic in a general way; Medium – an intermediate version, in which the most difficult […]

Deepak L Bhatt 1, Michael Szarek 1, Bertram Pitt 1, Christopher P Cannon 1, Lawrence A Leiter 1, Darren K McGuire 1, Julia B Lewis 1, Matthew C Riddle 1, Silvio E Inzucchi 1, Mikhail N Kosiborod 1, David Z I Cherney 1, Jamie P Dwyer 1, Benjamin M Scirica 1, Clifford J Bailey 1, […]

Steven B Heymsfield 1, Annaswamy Raji 2, Silvina Gallo 3, Jie Liu 2, Annpey Pong 2, Hakima Hannachi 2, Steven G Terra 4 Main idea: Meaningful reductions in HbA1c, fasting plasma glucose, BW, and SBP were observed with ertugliflozin in patients with overweight and obesity with type 2 diabetes mellitus. Ertugliflozin improved HbA1c and SBP […]

Filip Gnesin 1, Anne Cathrine Baun Thuesen 2 3, Lise Katrine Aronsen Kähler 4, Sten Madsbad 5, Bianca Hemmingsen 6 Main idea: There is no clear evidence whether metformin monotherapy compared with no intervention, behaviour changing interventions or other glucose-lowering drugs influences patient-important outcomes. Abstract Background: Worldwide, there is an increasing incidence of type 2 […]

Yifei Zhang 1, Yanyun Gu 1, Huahui Ren 2, Shujie Wang 1, Huanzi Zhong 2, Xinjie Zhao 3, Jing Ma 4, Xuejiang Gu 5, Yaoming Xue 6, Shan Huang 7, Jialin Yang 8, Li Chen 9, Gang Chen 10, Shen Qu 11, Jun Liang 12, Li Qin 13, Qin Huang 14, Yongde Peng 15, Qi […]

Apostolos Tsapas 1, Ioannis Avgerinos 2, Thomas Karagiannis 2, Konstantinos Malandris 2, Apostolos Manolopoulos 2, Panagiotis Andreadis 3, Aris Liakos 2, David R Matthews 4, Eleni Bekiari Main idea: In diabetic patients at low cardiovascular risk, no treatment differs from placebo for vascular outcomes. In patients at increased cardiovascular risk receiving metformin-based background therapy, specific […]

Tali Cukierman-Yaffe 1, Hertzel C Gerstein 2, Helen M Colhoun 3, Rafael Diaz 4, Luis-Emilio García-Pérez 5, Mark Lakshmanan 5, Angelyn Bethel 5, Denis Xavier 6, Jeffrey Probstfield 7, Matthew C Riddle 8, Lars Rydén 9, Charles Messan Atisso 5, Stephanie Hall 10, Purnima Rao-Melacini 10, Jan Basile 11, William C Cushman 12, Edward Franek […]

Suetonia C Palmer 1, Britta Tendal 2, Reem A Mustafa 3 4, Per Olav Vandvik 5, Sheyu Li 6 7, Qiukui Hao 8, David Tunnicliffe 9, Marinella Ruospo 10, Patrizia Natale 9 10, Valeria Saglimbene 10, Antonio Nicolucci 11, David W Johnson 12, Marcello Tonelli 13, Maria Chiara Rossi 11, Sunil V Badve 14, Yeoungjee […]

Daisuke Yabe 1, Jiro Nakamura 2, Hideaki Kaneto 3, Srikanth Deenadayalan 4, Andrea Navarria 4, Mette Gislum 4, Nobuya Inagaki 5, PIONEER 10 Investigators Main idea: Oral semaglutide was well tolerated in Japanese patients with type 2 diabetes. Once-daily oral semaglutide significantly reduced HbA1c (14 mg dose) and bodyweight (7 mg and 14 mg doses) […]